Status:
UNKNOWN
A Longitudinal Study to Analyse the Correlation Between CAI and Bilirubin
Lead Sponsor:
Guy's and St Thomas' NHS Foundation Trust
Collaborating Sponsors:
University of Oxford
Conditions:
Hemolysis Neonatal
Eligibility:
All Genders
Up to 1 years
Brief Summary
In newborns, intravascular hemolysis (the breakdown of red blood cells inside the blood vessels) can range from mild, as part of the physiological (normal) turnover of red blood cells, to severe in ca...
Detailed Description
In newborns, intravascular hemolysis can range from mild, as part of the physiological turnover of red blood cells, to severe in cases such as jaundice or ABO incompatibility. Early biomarkers of haem...
Eligibility Criteria
Inclusion
- Greater than 36 weeks gestation infants admitted to the neonatal unit and expected to be an in-patient for at least 5 days
Exclusion
- Babies with chromosomal abnormalities
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05287607
Start Date
June 1 2022
End Date
May 31 2024
Last Update
March 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.